Publication date: 1 June 2018
Source:Cell Stem Cell, Volume 22, Issue 6
Author(s): Takanori Takebe, James M. Wells, Michael A. Helmrath, Aaron M. Zorn
The meteoric rise in stem-cell-derived organoid technologies has ushered in a new era of "organoid medicine." Here we discuss how an organoid center can accelerate the translation of laboratory proof-of-principle experiments into clinical practice by developing and utilizing shared platforms for commercial and medical applications.
Teaser
The meteoric rise in stem-cell-derived organoid technologies has ushered in a new era of "organoid medicine." Here we discuss how an organoid center can accelerate the translation of laboratory proof-of-principle experiments into clinical practice by developing and utilizing shared platforms for commercial and medical applications.https://ift.tt/2LfsMsC
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου